搜索
361004350014R737．9B1001-5930201201-0098-031。、。。11．1NCI1999。。1．2Perou12000luminalsubtype、basal-likesubtype、2humanepidermalgrowthfactorreceptor-2HER-2、HER-2over-expres-sionsubtypenormalbreast-likesubtype。2003Sorlie2AB/C。Perou、Sorlie。、、。estrogenreceptorER、progester-onereceptorPRHER-24luminalA、luminalB、HER-2basal-like。basal-likeER、PR、HER-2。22．1luminalALuminalAERPRHER-2Ki67。44．5%～69．0%3。CK8/18Badve4luminalAForkhead-boxA1FOXA184%。FOXA1luminalA1。luminalA40%ER。HER-2。51824luminalA25．9%、10．3%348．1%～62．5%25．0%～40．0%P＜0．05luminalA。2．2HER-2HER-2ER、PRHER-2Ki-67。HER-2+++FISH。20%～30%HER-2。。HER-2ERBB217TRAP100、GRB76～11RRM2、RAD5。ER、PR。。HER-2HER-2。trastuzumab1HER-2FDA1998HER-2。HER-2。Slamon12、Marty13。、、。。Konecny14。lapatinib1EGFRHER-22007FDAHER-2·89·20121271ThePracticalJournalofCancerJanuary2012Vol27No．1。。NSABPB-31、HERA50%15～172006FDAHER-2。2．3luminalBluminalBERPRHER-2。HER-2lu-minalA。18luminalB88%。HER-2。2011NCCN＞1cm、1、0．6～1cm、23、±1±3≤0．5cm0．6～1cm、1、≤2mm。2．4basal-like1。ER、PR、HER-2basal-like5%～45%ER1914%HER-22080%～90%basal-like19。Nielsen21ER、HER-2CK5/6、CK14、CK171EGFR。。CK5/6basal-like。47～55。basal-like18．9%～28．8%22～24CK5/6、CK14vimentin85%p5360%EGFR25、、、。1、。HER-2。EGFR、MAP。dasatinib1BCR-ABLSRCbasal-like2627。basal-likeEGFRbevacizumab2829。2．5normalbreast-likeNormalbreast-likeER、HER-2CK5/6、CK14、CK17、EGFR。。。。1CER、PRHER-2。HER-2HER-2。C。VanCalster30。HER-2。HER-231。。“、”。1PerouCMSorlieTEisenMBetal．Molecularportraitsofhumanbreasttumors〔J〕．Nature20004066797747．2SorlieTTibshiraniRParkerJetal．Repeatedobservationofbreasttumorsubtypesinindependentgeneexpressiondatasets〔J〕．ProcNatlAcadSciUSA2003100148418．3．〔J/CD〕．200932195．4BadveSTurbinDThoratMAetal．FOXA1expressioninbreastcancer-correlationwithluminalsubtypeAandsurvival〔J〕．ClinCancerRes20071315Pt14415．5．〔J〕．2009364199．6BockerWMollRPorembaCetal．Commonadultstemcellsinthehumanbreastgiverisetoglandularandmyoepithelialcelllineagesanewcellbiologicalconcept〔J〕．LabInvest2002826737．7BoeckerWBuergerH．Evidenceofprogenitorcellsofglandularandmyoepithelialcelllineagesinthethehumanadultfemalebreastepi-theliumanewprogenitoradultstemcellconcept〔J〕．CellProlif200336Suppl173．8StinglJEavesCJZandiehIetal．Characterizationofbipotentmam-maryepithelialprogenitorcellsinnormaladulthumanbreasttissue〔J〕．BreastCancerResTreat200167293．·99·20121271ThePracticalJournalofCancerJanuary2012Vol27No．19DontuGAbdallahWMFoleyJMetal．Invitropropagationandtranscriptionalprofilingofhumanmammarystem/progenitorcells〔J〕．GenesDev200317101253．10DontuGAlHajjMAbdallahWMetal．Stemcellsinnormalbreastdevelopmentandbreastcancer〔J〕．CellProlif200336Suppl159．11BirnbaumDBertucciFGinestierCetal．Basalandluminalbreastcancersbasicorluminous〔J〕．IntJOncol2004252249．12SlamonDJLeyland-JonesBShakSetal．UseofchemotherapyplusamonoclonalantibodyagainstHER2formetastaticbreastcancerthatoverexpressesHER2〔J〕．NEngJMed200134411783．13MartyMCogneticFMaraninchiDetal．RandomizedphaseIItrialoftheefficacyandsafetyoftrastuzumabcombinedwithdocetaxelinpatientswithhumanepidermalgrowthfactorreceptor2-positivemeta-staticbreastcanceradministeredasfirst-linetreatmenttheM77001studygroup〔J〕．JClinOncol200523194265．14KonecnyGEPegramMDVenkatesanetal．Activityofthedualki-naseinhibitorlapatinibGW572016againstHER-2-overexpressingandtrastuzumab-treatedbreastcancercells〔J〕．CancerRes20066631630．15RomondEHPerezEABryantJetal．Trastuzumabplusadjuvantc-hemotherapyforoperableHER-2-positivebreastcancer〔J〕．NEnglJMed2005353161673．16PiccartGebhartMJProcterMLeylandJonesBetal．TrastuzumabafteradjuvantchemotherapyinHER-2-positivebreastcancer〔J〕．NEnglJMed2005353161659．17JoensuuHKellokumpuLehtinenPLBonoPetal．Adjuvantdocet-axelorvinorelbinewithorwithouttrastuzumabforbreastcancer〔J〕．NEnglJMed20063548809．18EllisMJCoopASinghBetal．Letrozoleismoreeffectiveneoadju-vantendocrinetherapythantamoxifenforErbB-1-and/orErbB-2-positiveestrogenreceptor-positiveprimarybreastcancerevidencefromaphaseⅢrandomizedtrial〔J〕．JClinOncol200119183808．19RakhaEAEl-sayedMEGreenARetal．Prognosticmarkersintri-ple-negativebreastcancer〔J〕．Cancer2007109125．20RouzierRPerouCMSymmansWFetal．Breastcancermoleculars-ubtypesresponddifferentlytopreoperativechemotherapy〔J〕．ClinCancerRes200511165678．21NielsenTOHsuFDJensenKetal．Immumohistochemicalandclini-calcharacterizationofthebasal-likesubtypeofinvasivebreastcarci-noma〔J〕．ClinCancerRes200410165367．22．〔J/CD〕．200932139．23．〔J〕．2009316447．24．〔J〕．2009304458．25SavageKLeungSToddSKetal．Distributionandsignificanceofcaveolin2expressioninnormalbreastandinvasivebreastcanceranimmunofluorescenceandimmunohistochemicalanalysis〔J〕．BreastCancerResTreat20081102245．26FinnRSDeringJGintherCetal．Dasatinibanorallyactivesmallmoleculeinhibitorofboththesrcandablkinasesselectivelyinhibitsgrowthofbasal-type/triple-negativebreastcancercelllinesgrow-inginvitro〔J〕．BreastCancerResTreat20071053319．27DizdarODedeDSBulutNetal．Dasatinibmayalsoinhibitc-Kitintriplenegativebreastcancercelllines〔J〕．BreastCancerResTreat20081072303．28MillerKWangMGralowJetal．Paclitaxelplusbevaci-zumabver-suspaclitaxelaloneformetastaticbreastcancer〔J〕．NEnglJMed2007357262666．29Mill